Cargando…
Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages
Oncostatin M (OSM) is a secreted cytokine mainly involved in chronic inflammatory and cardiovascular diseases through binding to OSM receptor β (OSMR-β). Recent studies demonstrated that the presence of OSM contributed to the destabilization of atherosclerotic plaque. To investigate whether OSMR-β d...
Autores principales: | Zhang, Xin, Li, Jing, Qin, Juan-Juan, Cheng, Wen-Lin, Zhu, Xueyong, Gong, Fu-Han, She, Zhigang, Huang, Zan, Xia, Hao, Li, Hongliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408608/ https://www.ncbi.nlm.nih.gov/pubmed/28258089 http://dx.doi.org/10.1194/jlr.M074112 |
Ejemplares similares
-
Swiprosin-1 deficiency in macrophages alleviated atherogenesis
por: Tong, Ling-Chang, et al.
Publicado: (2021) -
Expression of nephronectin is inhibited by oncostatin M via both JAK/STAT and MAPK pathways
por: Kurosawa, Tamaki, et al.
Publicado: (2015) -
Isoliquiritigenin Attenuates Atherogenesis in Apolipoprotein E-Deficient Mice
por: Du, Fen, et al.
Publicado: (2016) -
CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes
por: Migita, Kiyoshi, et al.
Publicado: (2011) -
Deficiency of Caspase-1 Attenuates HIV-1-Associated Atherogenesis in Mice
por: Alam, Mohammad Afaque, et al.
Publicado: (2023)